Hostname: page-component-76d6cb85b7-lrvh5 Total loading time: 0 Render date: 2026-07-15T06:21:32.810Z Has data issue: false hasContentIssue false

HPPD inhibitor-susceptible soybean growth, yield, and economic return following isoxaflutole and mesotrione applied postemergence

Published online by Cambridge University Press:  23 August 2022

Daniel O. Stephenson IV*
Affiliation:
Professor, Dean Lee Research and Extension Center, Louisiana State University Agricultural Center, Alexandria, LA, USA
Donnie K. Miller
Affiliation:
Professor, Northeast Research Station, Louisiana State University Agricultural Center, St Joseph, LA, USA
Jason A. Bond
Affiliation:
Extension/Research Professor, Department of Plant and Soil Sciences, Mississippi State University, Delta Research and Extension Center, Stoneville, MS, USA
Michael A. Deliberto Jr
Affiliation:
Assistant Professor, Department of Agricultural Economics and Agribusiness, Louisiana State University Agricultural Center, Baton Rouge, LA, USA
*
Author for correspondence: Daniel O. Stephenson IV, Louisiana State University Agricultural Center, Dean Lee Research and Extension Center, Alexandria, LA, USA 71302. (Email: dstephenson@agcenter.lsu.edu)
Rights & Permissions [Opens in a new window]

Abstract

The use of different herbicide-resistant soybean technologies in proximity could lead to injury and yield loss due to an application error. Research was initiated to evaluate the effect of 6.25%, 12.5%, and 100% doses of isoxaflutole and mesotrione field use doses applied postemergence to 4-hyroxyphenylpyruvate (HPPD) inhibitor-susceptible soybean, representing physical drift or misapplication doses. Visible injury manifested as chlorosis with slight necrosis, progressing to necrosis and height reduction, with visible height reduction as the only symptom. Isoxaflutole at 6.25% and 12.5% injured V2 soybean more than V1 or V4 soybean at all evaluation dates. This is supported by soybean height data at 14, 28, and 42 d after treatment (DAT). Following the 100% dose, maximum injury occurred at 28 DAT with V1, V2, and V4 soybean injured 90%, 85%, and 72%, but injury declined over time. All isoxaflutole treatments reduced yield at least 310 kg ha−1, with no differences among application timings or between the two lowest doses for a revenue loss of US$147 ha−1 to US$623 ha−1. Visible injury following mesotrione manifested as chlorosis and necrosis advancing to visible height reduction. Following mesotrione at 6.25% and 12.5%, injury ranged from 20% to 36% among application timings and did not differ at 3 to 21 DAT. Soybean heights at 28 and 42 DAT do not support injury observations; therefore, the greater injury was due to chlorosis and necrosis. Following mesotrione at 100%, sensitivity decreased at 3 to 14 DAT when applied to later growth stages, with no differences at 42 DAT. Yields did not differ among application timings, but yield losses were at least 240 kg ha−1, with revenue losses of US$60 ha−1 and US$373 ha−1. Producers are cautioned to prevent off-target movement or errant application of isoxaflutole or mesotrione to HPPD inhibitor-susceptible soybean.

Information

Type
Research Article
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the Weed Science Society of America
Figure 0

Table 1. Soybean variety and dates of planting, V1, V2, and V4 application timings, and harvest in research conducted from 2017 to 2019 at Alexandria and St Joseph, LA, and Stoneville, MS.

Figure 1

Table 2. Air and soil temperatures and relative humidity (RH) at V1, V2, and V4 application timings in research conducted from 2017 to 2019 at Alexandria and St Joseph, LA, and Stoneville, MS.

Figure 2

Table 3. Soybean height as a percent of the nontreated as influenced by the interaction of application timing and isoxaflutole dose in the isoxaflutole study conducted from 2017 to 2019 at Alexandria and St Joseph, LA, and Stoneville, MS.a

Figure 3

Table 4. Soybean yields, yield loss, and revenue loss in the isoxaflutole study and mesotrione study conducted from 2017 to 2019 at Alexandria and St Joseph, LA, and Stoneville, MS.a

Figure 4

Figure 1. Visible soybean injury in the isoxaflutole study following treatments applied to V1, V2, or V4 soybean as a function of days after treatment (DAT) at (A) 6.25%, (B) 12.5%, and (C) 100% of the field use dose of 105 g ai ha−1 at Alexandria and St Joseph, LA, and Stoneville, MS, in 2017, 2018, and 2019. Sample means represent 3, 7, 14, 28, and 42 DAT. Error bars represent ±1 SE.

Figure 5

Table 5. Soybean height as a percent of the nontreated as influenced by the interaction of application timing and mesotrione dose in the mesotrione study conducted from 2017 to 2019 at Alexandria and St Joseph, LA, and Stoneville, MS.a

Figure 6

Figure 2. Visible soybean injury in the mesotrione study following treatments applied to V1, V2, or V4 soybean as a function of days after treatment (DAT) at (A) 6.25%, (B) 12.5%, and (C) 100% of the field use dose of 176 g ai ha−1 at Alexandria and St Joseph, LA, and Stoneville, MS, in 2017, 2018, and 2019. Sample means represent 3, 7, 14, 28, and 42 DAT. Error bars represent ±1 SE.